2020
DOI: 10.1038/s41467-020-19170-5
|View full text |Cite
|
Sign up to set email alerts
|

The HUSH complex is a gatekeeper of type I interferon through epigenetic regulation of LINE-1s

Abstract: The Human Silencing Hub (HUSH) complex is necessary for epigenetic repression of LINE-1 elements. We show that HUSH-depletion in human cell lines and primary fibroblasts leads to induction of interferon-stimulated genes (ISGs) through JAK/STAT signaling. This effect is mainly attributed to MDA5 and RIG-I sensing of double-stranded RNAs (dsRNAs). This coincides with upregulation of primate-conserved LINE-1s, as well as increased expression of full-length hominid-specific LINE-1s that produce bidirectional RNAs,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
89
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(96 citation statements)
references
References 78 publications
7
89
0
Order By: Relevance
“…The outcome of the impaired TE upregulation is a reduced dysfunctional early IFN response, which may result in an exacerbated inflammatory response leading possibly to a cytokine storm, manifested clinically by severe acute respiratory distress syndrome (ARDS) with systemic consequences, such as disseminated intravascular coagulation (Garcia, 2020; Park and Iwasaki, 2020). This is in line with previous works which demonstrate the effectiveness of reverse transcriptase inhibitors as a treatment to reduce IFN activation (De Cecco et al, 2019; Tunbak et al, 2020). Therefore, we propose that TE activation could be used as a therapeutic tool to generate higher cellular IFN response against SARS-CoV-2 infection.…”
Section: Discussionsupporting
confidence: 93%
“…The outcome of the impaired TE upregulation is a reduced dysfunctional early IFN response, which may result in an exacerbated inflammatory response leading possibly to a cytokine storm, manifested clinically by severe acute respiratory distress syndrome (ARDS) with systemic consequences, such as disseminated intravascular coagulation (Garcia, 2020; Park and Iwasaki, 2020). This is in line with previous works which demonstrate the effectiveness of reverse transcriptase inhibitors as a treatment to reduce IFN activation (De Cecco et al, 2019; Tunbak et al, 2020). Therefore, we propose that TE activation could be used as a therapeutic tool to generate higher cellular IFN response against SARS-CoV-2 infection.…”
Section: Discussionsupporting
confidence: 93%
“…In hematological datasets, expression from a diverse array of TEs, including ERVs, SINEs, and LINEs, has been linked with viral mimicry upon DNMTi treatment [ 182 ]. Inactivation of the HUSH complex component MPP8 leads to both ERV and L1 upregulation, with the latter associated with dsRNA production and a type I interferon response [ 183 ]. Global ERV expression levels have been found to not predict clinical response of myelodysplasias treated with DNMTis [ 184 ].…”
Section: Therapeutic Modulation Of Erv Expression In Cancermentioning
confidence: 99%
“…Epigenetic regulation is a fundamental mechanism employed by cells to silence genes whose actions are either not needed or are potentially deleterious [ 132 ]. This mechanism of transcriptional repression operates on L1 [ 132 ] and HERVs and is initiated by DNA methyltransferase 1 (DNMT1) [ 133 ], which methylates the 5-position of cytosine in genomic CpG islands, attracting several silencing factors such as the human silencing hub (HUSH) complex [ 134 ] and histone modifiers [ 135 ] to effectively suppress transcription. Next, RNA interference and silencing activities of small interfering RNAs (siRNAs), miRNAs, and Piwi-interacting RNAs (piRNAs) act to prevent retrotransposon mRNA translation [ 136 ].…”
Section: How L1 Retrotransposons May Trigger Ifn-positive Slementioning
confidence: 99%